IRTCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
iRhythm Holdings, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$109.60+0.94 (+0.87%)
Close on Oct 19, 2026
- Market cap
- $3.61B
- P/E (TTM)
- –
- Dividend yield
- –
iRhythm statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Surgical & Medical Instruments & Apparatus companies for comparison
Valuation
| Measure | iRhythm | Industry median |
|---|---|---|
| Market Cap | $3.61B | $230.55M |
| Enterprise Value | $3.12B | $202.97M |
| PS Ratio | 4.38 | 3.10 |
| PB Ratio | 19.43 | 3.04 |
| P/TBV Ratio | 19.52 | 4.43 |
| P/FCF Ratio | 92.69 | 27.30 |
| P/OCF Ratio | 42.01 | 22.47 |
Enterprise value
| Measure | iRhythm | Industry median |
|---|---|---|
| EV / Sales | 3.78 | 2.91 |
| EV / FCF | 79.98 | 27.89 |
Income (trailing twelve months)
| Measure | iRhythm | Industry median |
|---|---|---|
| Revenue | $825.34M | $102.39M |
| Gross Profit | $589.74M | $60.36M |
| Operating Income | -$24.87M | -$4.31M |
| Pretax Income | -$12.98M | -$2.37M |
| Net Income | -$13.95M | -$6.57M |
| EBITDA | -$4.27M | -$1.98M |
| EPS (Diluted) | -$0.43 | -$0.08 |
Margins
| Measure | iRhythm | Industry median |
|---|---|---|
| Gross Margin | 71.5% | 55.2% |
| Operating Margin | -3.01% | -6.04% |
| Pretax Margin | -1.57% | -4.11% |
| Profit Margin | -1.69% | -10.5% |
| EBITDA Margin | -0.52% | -2.67% |
| FCF Margin | 4.72% | 0.02% |
Returns
| Measure | iRhythm | Industry median |
|---|---|---|
| Return on Equity (ROE) | -9.63% | -18.2% |
| Return on Assets (ROA) | -1.36% | -13.3% |
| Return on Capital Employed (ROCE) | -2.77% | -9.07% |
Growth
| Measure | iRhythm | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 25.6% | 8.85% |
| FCF Growth (YoY) | 39.8% | 9.68% |
| Revenue Growth (3Y CAGR) | 22.1% | 7.08% |
| Revenue Growth (5Y CAGR) | 23.0% | 11.8% |
Balance sheet
| Measure | iRhythm | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $495.36M | $36.66M |
| Net Cash (Debt) | $495.36M | $3.92M |
| Net Cash Per Share | $15.03 | $0.28 |
| Equity (Book Value) | $185.98M | $55.33M |
| Book Value Per Share | $5.64 | $2.87 |
| Tangible Book Value | $185.12M | $10.79M |
| Working Capital | $559.86M | $56.72M |
Financial position
| Measure | iRhythm | Industry median |
|---|---|---|
| Current Ratio | 3.85 | 2.48 |
| Quick Ratio | 2.96 | 1.53 |
| Interest Coverage | -1.89 | -1.85 |
Cash flow (trailing twelve months)
| Measure | iRhythm | Industry median |
|---|---|---|
| Operating Cash Flow | $86.00M | -$566.22K |
| Capital Expenditures | -$47.02M | -$3.69M |
| Free Cash Flow | $38.98M | -$696.00K |
| FCF Per Share | $1.18 | -$0.02 |
Efficiency
| Measure | iRhythm | Industry median |
|---|---|---|
| Asset Turnover | 0.80 | 0.58 |
| Inventory Turnover | 11.52 | 2.21 |
| Revenue Per Employee | $343.89K | $322.92K |
| Profits Per Employee | -$5.81K | -$51.88K |
| Employee Count | 2,400 | 185 |
Dividends and yields
| Measure | iRhythm | Industry median |
|---|---|---|
| Earnings Yield | -0.39% | -6.88% |
| FCF Yield | 1.08% | -0.45% |
Shares
| Measure | iRhythm | Industry median |
|---|---|---|
| Shares Outstanding | 32,963,000 | 44,302,700 |
| Shares Change (YoY) | 2.89% | 3.36% |
| Shares Change (QoQ) | 0.27% | 0.27% |
| Float | 32,271,200 | 37,462,700 |
| Shares Held by Insiders | 2.10% | 10.5% |
| Shares Held by Institutions | 108.2% | 63.5% |
Taxes
| Measure | iRhythm | Industry median |
|---|---|---|
| Income Tax | $971.00K | $1.52M |
Scores
| Measure | iRhythm | Industry median |
|---|---|---|
| Altman Z-Score | 2.64 | 1.95 |
| Piotroski F-Score | 5 | 5 |
| Beneish M-Score | -3.14 | -2.64 |
Calculated by StockData from iRhythm's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.